Jing Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jing Liu has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Wenying Zhang
Gynecology Department, Changning Maternity and Infant Health Hospital, East China Normal University, No. 786, Yuyuan Road, Changning District, Shanghai, 200051, China
2 shared publications Yu Liu
Department of Gynecology, Changning Maternity and Infant Health Hospital, 200000 Shanghai, China
2 shared publications- Chengbin Ma
Changning Maternity and Infant Health Hospital, Shanghai Key Laboratory of Regulatory Biology, School of Life Sciences, East China Normal University
1 shared publication - Chengbin Ma
Department of Gynecology, Changning Maternity and Infant Health Hospital, 200000 Shanghai, China
1 shared publication Jiajun Shen
Department of Gynecology, Changning Maternity and Infant Health Hospital, 200000 Shanghai, China
1 shared publicationQiongwei Wu
Department of Gynecology, Shanghai Changning Maternity and Infant Health Hospital, Shanghai 200051, China
1 shared publication
Latest Publications
- Open Access
- 26 February 2025
- Published by IMR Press in Clinical and Experimental Obstetrics & Gynecology
- Vol. 52 (2) , 24896
Fertility Outcome after Tubal Flushing in Patients Undergoing Salpingectomy for Tubal Ectopic Pregnancy: A Prospective Cohort Study
Background: To examine the effect of tubal flushing on the fertility outcome of patients with tubal ectopic pregnancy (EP) undergoing salpingectomy. Methods: This prospective cohort study included 93 patients who received unilateral salpingectomy for tubal EP. Tubal flushing via hysteroscopic hydrotubation was performed after surgery on only 42 patients in the cohort. All patients were followed up for their fertility outcomes by phone interview. Results: Intrauterine pregnancy (IUP) was documented in 48 cases. The cumulative IUP rate was 64.6% in the patients who received tubal flushing, and 54.7% in the patients without tubal flushing (p = 0.071). The median time from salpingectomy to IUP was 13.0 months in the patients with tubal flushing and 27.1 months in those without tubal flushing (p = 0.007). Recurrent ectopic pregnancy (REP) was documented in three (7.1%) of the patients who received tubal flushing and two (3.9%) that did not (p = 0.823). Conclusions: Tubal flushing via hysteroscopic hydrotubation after unilateral salpingectomy may improve subsequent IUP after EP but cannot prevent REP. Clinical Trial Registration: The study protocol was registered to the Chinese Clinical Trial Registry at https://www.chictr.org.cn/ (Identifier No.: ChiCTR2100052941).
- 26 February 2025
- Published by IMR Press in Clinical and Experimental Obstetrics & Gynecology
- Vol. 52 (2) , 24896
Open AccessFertility Outcome after Tubal Flushing in Patients Undergoing Salpingectomy for Tubal Ectopic Pregnancy: A Prospective Cohort Study
Background: To examine the effect of tubal flushing on the fertility outcome of patients with tubal ectopic pregnancy (EP) undergoing salpingectomy. Methods: This prospective cohort study included 93 patients who received unilateral salpingectomy for tubal EP. Tubal flushing via hysteroscopic hydrotubation was performed after surgery on only 42 patients in the cohort. All patients were followed up for their fertility outcomes by phone interview. Results: Intrauterine pregnancy (IUP) was documented in 48 cases. The cumulative IUP rate was 64.6% in the patients who received tubal flushing, and 54.7% in the patients without tubal flushing (p = 0.071). The median time from salpingectomy to IUP was 13.0 months in the patients with tubal flushing and 27.1 months in those without tubal flushing (p = 0.007). Recurrent ectopic pregnancy (REP) was documented in three (7.1%) of the patients who received tubal flushing and two (3.9%) that did not (p = 0.823). Conclusions: Tubal flushing via hysteroscopic hydrotubation after unilateral salpingectomy may improve subsequent IUP after EP but cannot prevent REP. Clinical Trial Registration: The study protocol was registered to the Chinese Clinical Trial Registry at https://www.chictr.org.cn/ (Identifier No.: ChiCTR2100052941).
- Open Access
- 10 September 2021
- Published by Hindawi Limited in Journal of Oncology
- Vol. 2021, 1-11
HOTAIR Contributes to Stemness Acquisition of Cervical Cancer through Regulating miR-203 Interaction with ZEB1 on Epithelial-Mesenchymal Transition
Cervical cancer stem cells contribute respond to considerable recurrence and metastasis of patients with cervical cancer. The stemness properties were partly regulated by the interaction of lncRNAs and miRNAs. HOTAIR functions as an oncogenic lncRNA. Previous research studies revealed its role in regulating stemness properties in various cancers. However, the role of HOTAIR in cervical cancer stem cells is still unknown. Here, cisplatin-resistant and serum-free cultured cells exhibited stem cells properties. Cervical cancer stem cells exhibited greater invasion and migration compared with their parental cells, which was similar to cells overexpressing HOTAIR. HOTAIR was significantly overexpressed in cervical cancer stem cells, and knockdown of HOTAIR generated statistical downregulation of stemness markers. Additionally, HOTAIR expression was negatively correlated with the level of miR-203, which was found to be an inhibitory miRNA in regulating the expressions of stemness markers. Also, miR-203 expression was negatively correlated with ZEB1. These findings suggested that HOTAIR should be a positive contributor in stemness acquisition of cervical cancer cells, and this effect should correlate with the interaction with miR-203, which can be suppressed by ZEB1.
- 10 September 2021
- Published by Hindawi Limited in Journal of Oncology
- Vol. 2021, 1-11
Open AccessHOTAIR Contributes to Stemness Acquisition of Cervical Cancer through Regulating miR-203 Interaction with ZEB1 on Epithelial-Mesenchymal Transition
Cervical cancer stem cells contribute respond to considerable recurrence and metastasis of patients with cervical cancer. The stemness properties were partly regulated by the interaction of lncRNAs and miRNAs. HOTAIR functions as an oncogenic lncRNA. Previous research studies revealed its role in regulating stemness properties in various cancers. However, the role of HOTAIR in cervical cancer stem cells is still unknown. Here, cisplatin-resistant and serum-free cultured cells exhibited stem cells properties. Cervical cancer stem cells exhibited greater invasion and migration compared with their parental cells, which was similar to cells overexpressing HOTAIR. HOTAIR was significantly overexpressed in cervical cancer stem cells, and knockdown of HOTAIR generated statistical downregulation of stemness markers. Additionally, HOTAIR expression was negatively correlated with the level of miR-203, which was found to be an inhibitory miRNA in regulating the expressions of stemness markers. Also, miR-203 expression was negatively correlated with ZEB1. These findings suggested that HOTAIR should be a positive contributor in stemness acquisition of cervical cancer cells, and this effect should correlate with the interaction with miR-203, which can be suppressed by ZEB1.